Sign in
4

Changes in Ownership

GALECTIN THERAPEUTICS INC Filed Acc 0001133416-22-000101

Chief Financial Officer bought 4,000 shares at $1.32 ($5,280)

From the SEC's structured data for this filing

Trades in this filing

CALLICUTT JACK W · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-11-17 Purchase : show line 1 in the form +4,000 $1.32 $5,280 7,614 D
Open-market purchases · 4,000 sh · avg $1.32 · $5,280
Loading xslF345X03/form4.xml…